BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36867660)

  • 41. Identification of High-Risk Human Papillomavirus DNA, p16, and E6/E7 Oncoproteins in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
    Lifsics A; Groma V; Cistjakovs M; Skuja S; Deksnis R; Murovska M
    Viruses; 2021 May; 13(6):. PubMed ID: 34072187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.
    Stiasny A; Kuhn C; Mayr D; Alexiou C; Janko C; Wiest I; Jeschke U; Kost B
    Anticancer Res; 2016 Jun; 36(6):3195-8. PubMed ID: 27272848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells.
    Marullo R; Werner E; Zhang H; Chen GZ; Shin DM; Doetsch PW
    Carcinogenesis; 2015 Nov; 36(11):1397-406. PubMed ID: 26354779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.
    Maher DM; Bell MC; O'Donnell EA; Gupta BK; Jaggi M; Chauhan SC
    Mol Carcinog; 2011 Jan; 50(1):47-57. PubMed ID: 21061268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human papillomavirus seropositivity and risks of head and neck cancer.
    Smith EM; Ritchie JM; Pawlita M; Rubenstein LM; Haugen TH; Turek LP; Hamsikova E
    Int J Cancer; 2007 Feb; 120(4):825-32. PubMed ID: 17131312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage.
    Park JW; Nickel KP; Torres AD; Lee D; Lambert PF; Kimple RJ
    Radiother Oncol; 2014 Dec; 113(3):337-44. PubMed ID: 25216575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes.
    Oh JE; Kim JO; Shin JY; Zhang XH; Won HS; Chun SH; Jung CK; Park WS; Nam SW; Eun JW; Kang JH
    Int J Oncol; 2013 Aug; 43(2):383-93. PubMed ID: 23708675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
    Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins.
    Grace M; Munger K
    Virology; 2017 Jan; 500():71-81. PubMed ID: 27771561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
    Hasan UA; Bates E; Takeshita F; Biliato A; Accardi R; Bouvard V; Mansour M; Vincent I; Gissmann L; Iftner T; Sideri M; Stubenrauch F; Tommasino M
    J Immunol; 2007 Mar; 178(5):3186-97. PubMed ID: 17312167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.
    Lace MJ; Anson JR; Klussmann JP; Wang DH; Smith EM; Haugen TH; Turek LP
    J Virol; 2011 Feb; 85(4):1645-54. PubMed ID: 21123375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine.
    Tseng SH; Liu L; Peng S; Kim J; Ferrall L; Hung CF; Wu T-
    J Biomed Sci; 2021 Sep; 28(1):63. PubMed ID: 34517865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of human papillomavirus 16 oncoproteins on oncostatin M upregulation in oral squamous cell carcinoma.
    Chuerduangphui J; Pientong C; Chaiyarit P; Patarapadungkit N; Chotiyano A; Kongyingyoes B; Promthet S; Swangphon P; Wongjampa W; Ekalaksananan T
    Med Oncol; 2016 Aug; 33(8):83. PubMed ID: 27349249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPV E6 and E7 oncoproteins cooperatively alter the expression of Disc Large 1 polarity protein in epithelial cells.
    Dizanzo MP; Marziali F; Brunet Avalos C; Bugnon Valdano M; Leiva S; Cavatorta AL; Gardiol D
    BMC Cancer; 2020 Apr; 20(1):293. PubMed ID: 32264889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation.
    Dust K; Carpenter M; Chen JC; Grant C; McCorrister S; Westmacott GR; Severini A
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of MicroRNAs That Stabilize p53 in Human Papillomavirus-Positive Cancer Cells.
    Martínez-Noël G; Szajner P; Kramer RE; Boyland KA; Sheikh A; Smith JA; Howley PM
    J Virol; 2022 Feb; 96(4):e0186521. PubMed ID: 34878887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
    Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
    Hatterschide J; Brantly AC; Grace M; Munger K; White EA
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
    Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.